Shandong Weigao Group Medical Polymer Co Ltd vs Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
A side-by-side look at two Chinese stocks — live quote, valuation, growth, listing venue, dual-listing and delisting status, and the WealthyTec Rank. A factual comparison for orientation, not investment advice.
| Metric | Shandong Weigao Group Medical Polymer Co Ltd 1066.HK · Hong Kong 3.29 HKD | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 1349.HK · Hong Kong 2.43 HKD |
|---|---|---|
| Day change | +2.49% | +2.53% |
| Market cap | $1.90B | $285.8M |
| P/E (TTM) | — | — |
| 2y EPS CAGR | — | — |
| WealthyTec Rank | 1.4 | 9.1 |
| Rank within sector | #26 of 31 | #3 of 31 |
| Listing venue | HKEX | HKEX |
| Other listings | n/a | n/a |
| Delisting filings | None on record | None on record |
| Sector | Health Care | Health Care |
| Industry | Medical Equipment and Devices | Medical Equipment and Devices |
Of the two, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd currently carries the higher WealthyTec Rank (9.1 vs 1.4). The Rank reflects past revenue, earnings and EPS trends only — not valuation, momentum, or the policy and delisting risks every China investor should weigh, and it is not a recommendation to buy, sell or hold either security. See our rank methodology.